Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts
Yang Shen et al, 2016, IJMS CrossRef
Fish Oil Feeding Modulates the Expression of Hepatic MicroRNAs in a Western-Style Diet-Induced Nonalcoholic Fatty Liver Disease Rat Model
Hualin Wang et al, 2017, BioMed Research International CrossRef
Identification and characterization of metformin on peptidomic profiling in human visceral adipocytes
Yao Gao et al, 2017, J Cell Biochem CrossRef
Novel roles for LIX1L in promoting cancer cell proliferation through ROS1-mediated LIX1L phosphorylation
Satoki Nakamura et al, 2015, Sci Rep CrossRef
Mechanism of gemcitabine-induced suppression of human cholangiocellular carcinoma cell growth
YUKA TOYOTA et al, 2015 CrossRef
Who watches the watchmen? Regulation of the expression and activity of sirtuins
Marcin Buler et al, 2016, The FASEB Journal CrossRef
Metformin Regulating miR-34a Pathway to Inhibit Egr1 in Rat Mesangial Cells Cultured with High Glucose
Can Wu et al, 2018, International Journal of Endocrinology CrossRef
Epigenetic effects of metformin: From molecular mechanisms to clinical implications
Stephanie Claire Bridgeman et al, 2018, Diabetes Obes Metab CrossRef
To die or not to die: death signaling in nonalcoholic fatty liver disease
Yuko Akazawa et al, 2018, J Gastroenterol CrossRef
TAM 2.0: tool for MicroRNA set analysis
Jianwei Li et al, 2018 CrossRef
Adipocyte alterations in endometriosis: reduced numbers of stem cells and microRNA induced alterations in adipocyte metabolic gene expression
Masoumeh Majidi Zolbin et al, 2019, Reprod Biol Endocrinol CrossRef
Metformin promotes proliferation and suppresses apoptosis in Ox-LDL stimulated macrophages by regulating the miR-34a/Bcl2 axis
Liuliu Feng et al, 2019, RSC Adv. CrossRef
MicroRNA‐223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes
Yong He et al, 2019, Hepatology CrossRef
Metformin inhibits high glucose-induced mesangial cell proliferation, inflammation and ECM expression through the SIRT1-FOXO1-autophagy axis.
Jiang Xu et al, 2019, Clin Exp Pharmacol Physiol CrossRef
Role of MicroRNAs in NAFLD/NASH
Gyongyi Szabo et al, 2016, Dig Dis Sci CrossRef
DJ-1 deficiency alleviates steatosis in cultured hepatocytes
Harmesh N. Chaudhari et al, 2015, Biotechnol Bioproc E CrossRef
An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present
Ans Jacobs et al, 2016 CrossRef
Mechanism of the Hypoglycemic Activity and Hepatoprotective Effect of the Aqueous Extract of Cecropia obtusifolia Bertol
María de los Ángeles Fortis-Barrera et al, 2019, Journal of Medicinal Food CrossRef
Descending Expression of miR320 in Insulin-Resistant Adipocytes Treated with Ascending Concentrations of Metformin
Yousof Naghiaee et al, 2020, Biochem Genet CrossRef
Endothelin-1 promotes epithelial-mesenchymal transition in human chondrosarcoma cells by repressing miR-300
Min-Huan Wu et al, 2016, Oncotarget CrossRef
Metformin-induced suppression of NLK improves erythropoiesis in pre-clinical models of Diamond Blackfan Anemia through induction of miR-26a.
MC Wilkes et al, 2020, Experimental Hematology CrossRef
Metformin downregulates miR223 expression in insulin-resistant 3T3L1 cells and human diabetic adipose tissue
Yousof Naghiaee et al, 2020, Endocrine CrossRef
Autophagy-regulating miRNAs: potential targets for obesity and related metabolic disorders
Tian Zhang et al, 2021, Drug Discovery Today CrossRef
Metformin and insulin-resistant related diseases: Emphasis on the role of microRNAs
Nahid Alimoradi et al, 2021, Biomedicine & Pharmacotherapy CrossRef
Metformin attenuates ischemia/reperfusion-induced apoptosis of cardiac cells by downregulation of p53/microRNA-34a via activation of SIRT1.
Weiwei Li et al, 2021, Can J Physiol Pharmacol CrossRef
Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA
Tomoko Tadokoro et al, 2021, IJMS CrossRef
Comparing the Effect of Cinnamaldehyde and Metformin on Expression of MiR320 and MiR26-b in Insulin Resistant 3T3L1 Adipocytes
Yousof Naghiaee et al, 2021, Phytomedicine Plus CrossRef
Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment
Chengyuan Liang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights
Kristen Stephenson et al, 2018, gene expr CrossRef
Role of microRNAs in the process of metformin treating multiple diseases
Ningning Ma et al, 2021 CrossRef
Advances in metformin for the treatment of non-alcoholic fatty liver disease in children
Qian-Long Wu et al, 2022, Expert Review of Gastroenterology & Hepatology CrossRef
Hepatic gene expression and functional changes associated with nonalcoholic steatohepatitis
Kana Matsumoto et al, 2022, Mol Med Rep CrossRef
Research progress of metformin in the treatment of liver fibrosis
Anqi Zhang et al, 2023, International Immunopharmacology CrossRef
Metformin: update on mechanisms of action on liver diseases
Gaoyi Ruan et al, 2023, Front. Nutr. CrossRef
Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity
Yi-Jie Li et al, 2024, World J Gastroenterol CrossRef
Tenascin-X is increased with decreased expression of miR-378a-5p and miR-486-5p in mice fed a methionine-choline-deficient diet that induces hepatic fibrosis
Ken-ichi MATSUMOTO et al, 2024, Biomed. Res. CrossRef
Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional Intervention
Ana Luz Tobaruela-Resola et al, 2024, Nutrients CrossRef
miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis.
Paola Dongiovanni et al, 2018, Int J Mol Sci CrossRef
Hepatic miR-363 promotes non-alcoholic fatty liver disease by suppressing INSIG1
Lechen Wang et al, 2024, The Journal of Nutritional Biochemistry CrossRef